EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $489 | -34.1% | 21,750 | -29.7% | 0.00% | -57.1% |
Q4 2023 | $742 | -57.4% | 30,932 | -61.2% | 0.01% | -65.0% |
Q3 2023 | $1,742 | +71.1% | 79,734 | +52.0% | 0.02% | +66.7% |
Q1 2023 | $1,018 | -62.9% | 52,465 | -69.3% | 0.01% | -63.6% |
Q4 2022 | $2,742 | -98.7% | 170,940 | +1145.4% | 0.03% | +1000.0% |
Q3 2022 | $215,000 | -74.1% | 13,726 | -65.6% | 0.00% | -66.7% |
Q2 2022 | $831,000 | -57.9% | 39,924 | -54.2% | 0.01% | -35.7% |
Q1 2022 | $1,975,000 | +4.8% | 87,139 | -15.4% | 0.01% | +40.0% |
Q4 2021 | $1,884,000 | +9.3% | 103,060 | +26.4% | 0.01% | +25.0% |
Q3 2021 | $1,724,000 | +247.6% | 81,557 | +199.5% | 0.01% | +300.0% |
Q2 2021 | $496,000 | -51.1% | 27,232 | -39.3% | 0.00% | -60.0% |
Q1 2021 | $1,014,000 | -71.2% | 44,879 | -74.4% | 0.01% | -73.7% |
Q4 2020 | $3,524,000 | +12.8% | 175,609 | +37.4% | 0.02% | -5.0% |
Q3 2020 | $3,125,000 | -0.4% | 127,831 | -3.2% | 0.02% | -23.1% |
Q2 2020 | $3,136,000 | +482.9% | 132,077 | +322.8% | 0.03% | +420.0% |
Q1 2020 | $538,000 | -85.2% | 31,235 | -84.8% | 0.01% | -84.8% |
Q4 2019 | $3,624,000 | +2564.7% | 205,694 | +2582.8% | 0.03% | +3200.0% |
Q3 2019 | $136,000 | -91.1% | 7,667 | -89.2% | 0.00% | -90.0% |
Q2 2019 | $1,520,000 | +5.2% | 71,121 | +17.1% | 0.01% | -23.1% |
Q1 2019 | $1,445,000 | +106.1% | 60,724 | +70.4% | 0.01% | +116.7% |
Q4 2018 | $701,000 | -37.3% | 35,626 | -43.5% | 0.01% | -25.0% |
Q3 2018 | $1,118,000 | +16.7% | 63,088 | +41.8% | 0.01% | -11.1% |
Q2 2018 | $958,000 | +111.0% | 44,501 | +117.2% | 0.01% | +125.0% |
Q1 2018 | $454,000 | -64.8% | 20,490 | -51.7% | 0.00% | -66.7% |
Q4 2017 | $1,288,000 | -74.1% | 42,384 | -79.4% | 0.01% | -72.7% |
Q3 2017 | $4,979,000 | +2520.5% | 205,472 | +2242.6% | 0.04% | +2100.0% |
Q1 2017 | $190,000 | -91.8% | 8,771 | -94.3% | 0.00% | -89.5% |
Q4 2016 | $2,307,000 | +572.6% | 154,726 | +476.6% | 0.02% | +375.0% |
Q3 2016 | $343,000 | +236.3% | 26,836 | +5.6% | 0.00% | +300.0% |
Q1 2016 | $102,000 | -24.4% | 25,424 | +5.6% | 0.00% | 0.0% |
Q3 2015 | $135,000 | +264.9% | 24,072 | -5.3% | 0.00% | – |
Q4 2014 | $37,000 | -84.6% | 25,413 | -83.8% | 0.00% | -100.0% |
Q3 2014 | $240,000 | +27.0% | 156,716 | +193.5% | 0.00% | 0.0% |
Q1 2014 | $189,000 | -2.1% | 53,392 | +61.0% | 0.00% | 0.0% |
Q3 2013 | $193,000 | +28.7% | 33,154 | +0.4% | 0.00% | 0.0% |
Q2 2013 | $150,000 | – | 33,022 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $320,572,000 | 64.48% |
Sargent Investment Group, LLC | 432,125 | $9,235,000 | 4.22% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 443,534 | $9,483,000 | 3.52% |
Bellevue Group AG | 3,878,800 | $82,890,000 | 1.42% |
CAPITAL MANAGEMENT CORP /VA | 237,855 | $5,083,000 | 1.40% |
Orbimed Advisors | 3,912,900 | $83,619,000 | 1.30% |
Portolan Capital Management | 540,590 | $11,552,000 | 1.24% |
TEALWOOD ASSET MANAGEMENT INC | 139,347 | $2,978,000 | 1.21% |
Signition LP | 84,120 | $1,798,000,000 | 1.18% |
Penn Capital Management Company, LLC | 529,630 | $11,318,000 | 1.12% |